Malignant hyperthermia — the two words one never wants to hear when administering general anesthesia. But when it does occur, be ready with Dantrium IV, a sterile, non-pyrogenic, lyophilized formulation of dantrolene sodium injection available from Par Pharmaceutical, an endo international company. Since the 1960s, it is Outpatient Surgery Magazine's understanding that Dantrium IV has reduced MH-related fatalities by 70%. The product has 36 months of shelf life, is easy to open, mixes in just 20 seconds, and is priced very competitively.
Your product information request has been received and we will forward information to the contact information you provided shortly.